| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -39.1% | -33.3% |
| ROCE | n/a |
| Latest | F'cast | |
|---|---|---|
| P/E | n/a | n/a |
| PEG | n/a | n/a |
| Pr/Revenue | 1.3 | 1.1 |
| Pr/Book | 0.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 13.3% | 14.8% |
| PBT | n/a | n/a |
| EPS | n/a | n/a |
| DPS | n/a | n/a |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-21 | 9.19 | 1.10 | 3.17p | 25.2 | 0.4 | +57% | n/a | 0.0% |
| 30-Sep-22 | 8.64 | 0.88 | 2.14p | 15.7 | n/a | -32% | n/a | 0.0% |
| 30-Sep-23 | 6.66 | (1.36) | (2.44)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-24 | 5.77 | (2.09) | (4.14)p | n/a | n/a | n/a | n/a | 0.0% |
| 30-Sep-25 | 6.53 | (2.45) | (1.85)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 30-Sep-26 | 7.50 | (2.50) | (1.80)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Correction: c.£1.5 million Contract Extension | 12-Feb-2026 | 08:48 | RNS |
| c.£1.5 million Contract Extension | 12-Feb-2026 | 07:00 | RNS |
| Appointment of Chief Commercial Officer | 05-Feb-2026 | 07:00 | RNS |
| One to watch: Phytopharm | 19-Jul-2011 | The Scotsman |
| Phytopharm soars 340% on drug trial | 15-Oct-2009 | The Independent |
| Need to know: InBev go ahead ... Citigroup job c... | 15-Nov-2008 | Times |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 8.88p |
| Change Today | 0.13p |
| % Change | 1.43 % |
| 52 Week High | 14.00 |
| 52 Week Low | 7.75 |
| Volume | 61,620 |
| Shares Issued | 92.67m |
| Market Cap | £8.22m |
| Beta | 0.68 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| No dividends found |
You are here: research